Skip to Main Content

Paper Details

THREE-YEAR TREATMENT OUTCOMES OF AFLIBERCEPT VERSUS RANIBIZUMAB FOR DIABETIC MACULAR EDEMA: Data from the Fight Retinal Blindness! Registry.
Retina
4
2022
Author NameAffiliation
Vuong NguyenThe University of Sydney, Sydney Medical School, Save Sight Institute
Hemal MehtaThe University of Sydney, Sydney Medical School, Save Sight Institute
Hemal MehtaRoyal Free London NHS Foundation Trust
Daniel BarthelmesThe University of Sydney, Sydney Medical School, Save Sight Institute
Daniel BarthelmesUniversity Hospital Zurich, University of Zurich
Mark C GilliesThe University of Sydney, Sydney Medical School, Save Sight Institute
  • 1 - 6

Datasets

Release 1.2